Literature DB >> 7492198

Blood eosinophil counts and arterial oxygen tension in acute asthma.

D Spallarossa1, O Sacco, D Girosi, G A Rossi.   

Abstract

OBJECTIVE: To investigate whether during acute asthma episodes a decrease in blood eosinophil count could correlate with the severity of the disease.
DESIGN: Prospective study on paediatric asthmatic patients admitted for acute asthma exacerbation between January 1992 and August 1993. All patients were regularly followed up in an outpatient clinic and had had a complete clinical evaluation < 1 month before admission.
SETTING: Pulmonary division of the G Gaslini paediatric research institute, Genoa, Italy.
SUBJECTS: 21 asthmatic patients, 59 (SEM 9) months of age, admitted for acute asthma exacerbation. On the basis of clinical evaluation and the results of blood and microbiological tests performed during acute asthma exacerbations, patients were divided into two subgroups: infected (n = 13) and non-infected (n = 8).
RESULTS: All but one of the patients showed a marked decrease in blood eosinophil count during the acute asthma episode, in comparison with recent count (< 1 month before admission) obtained in clinically stable conditions: 662 (116) v 210 (54) eosinophils/mm3, p < 0.0003. The decrease in the eosinophil count was more pronounced in the infected patients than in the non-infected patients, but the difference was not statistically significant (p > 0.05). Similarly, transcutaneous arterial oxygen pressure (PaO2) values measured during acute asthma exacerbations tended to be lower in infected patients, without, however, reaching statistical significance: 8.6 (0.7) v 10.1 (0.9) kPa, p > 0.05). The correlation between the decrease in blood eosinophil count and PaO2 during the acute asthma exacerbations was significant in all the patients (r2 = 0.235, p = 0.022) and in the non-infected patients (r2 = 0.653, p = 0.015), but not in infected patients. In this latter subgroup, a significant negative correlation was found between blood neutrophil counts during acute asthma exacerbations and PaO2 (r2 = 349, p = 0.026).
CONCLUSIONS: During acute asthma exacerbations in atopic patients without clinical evidence of infection, the decrease in blood eosinophil count correlates significantly with the decrease in PaO2, further supporting the role of eosinophils in allergic asthma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492198      PMCID: PMC1511355          DOI: 10.1136/adc.73.4.333

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  30 in total

1.  IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.

Authors:  G Del Prete; E Maggi; P Parronchi; I Chrétien; A Tiri; D Macchia; M Ricci; J Banchereau; J De Vries; S Romagnani
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

Review 2.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

3.  Falls in peripheral eosinophil counts parallel the late asthmatic response.

Authors:  W O Cookson; C F Craddock; M K Benson; S R Durham
Journal:  Am Rev Respir Dis       Date:  1989-02

4.  Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates.

Authors:  R H Gundel; L G Letts; G J Gleich
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions.

Authors:  J G De Monchy; H F Kauffman; P Venge; G H Koëter; H M Jansen; H J Sluiter; K De Vries
Journal:  Am Rev Respir Dis       Date:  1985-03

6.  Comparison of whole-blood eosinophil counts in extrinsic asthmatics with acute and chronic asthma.

Authors:  A R Luksza; D K Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-30

7.  Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.

Authors:  D J Warren; M A Moore
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

8.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.

Authors:  E J Clutterbuck; E M Hirst; C J Sanderson
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

9.  Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids.

Authors:  A M Lamas; G V Marcotte; R P Schleimer
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

10.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  1 in total

1.  Blood and sputum eosinophils in COPD; relationship with bacterial load.

Authors:  Umme Kolsum; Gavin C Donaldson; Richa Singh; Bethan L Barker; Vandana Gupta; Leena George; Adam J Webb; Sarah Thurston; Anthony J Brookes; Timothy D McHugh; Jadwiga A Wedzicha; Christopher E Brightling; Dave Singh
Journal:  Respir Res       Date:  2017-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.